Lacosamida Opko

Lacosamide, the active ingredient in Lacosamida Opko, is a sodium channel blocker presented as a tablet for oral use. It is used to treat focal seizures in patients with epilepsy.

GNH USA supplies Lacosamida Opko as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an antiepileptic drug that targets neuronal hyperexcitability in focal seizure disorders. - Focal seizures: reduces seizure frequency in patients with focal epilepsy. - Partial‑onset seizures: provides adjunctive control when other therapies are insufficient. - Adjunctive therapy for epilepsy: used together with other antiepileptics to improve overall seizure management.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient light‑headedness, especially after dose initiation. - Fatigue: feeling unusually tired or low‑energy. - Nausea: mild stomach upset or queasiness. - Headache: pressure or throbbing pain in the head. - Diplopia: occasional double vision. - Somnolence: increased sleepiness during the day.

Serious or Rare Side Effects: - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Severe skin reactions: rare cases of Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmia: potential PR‑interval prolongation. - Liver enzyme elevation: abnormal hepatic function tests. - Hypersensitivity: rash, swelling, or anaphylactic signs. - Blood dyscrasias: rare reports of agranulocytosis or thrombocytopenia.

Before initiating therapy, consider the following safety measures. - Renal impairment: assess renal function and monitor for accumulation. - Hepatic impairment: use with caution and monitor liver enzymes. - Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional. - Concomitant CNS depressants: monitor for additive sedation or respiratory depression. - Suicidal ideation: observe mood changes and report any thoughts of self‑harm. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lacosamide can interact with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, lowering lacosamide plasma levels. - Phenytoin: reduces lacosamide exposure through enzyme induction. - Rifampin: decreases lacosamide concentrations via hepatic enzyme induction.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may increase sedation and respiratory depression. - Alcohol: can enhance dizziness and drowsiness. - Antidepressants (e.g., SSRIs): monitor for potential QT‑interval prolongation.